- Home
- MOD vs JAZZ Comparison
MOD vs JAZZ Comparison
Compare MOD & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOD
- JAZZ
- Stock Information
- Founded
- MOD 1916
- JAZZ 2003
- Country
- MOD United States
- JAZZ Ireland
- Employees
- MOD N/A
- JAZZ N/A
- Industry
- MOD Auto Parts:O.E.M.
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- MOD Consumer Discretionary
- JAZZ Health Care
- Exchange
- MOD Nasdaq
- JAZZ Nasdaq
- Market Cap
- MOD 7.1B
- JAZZ 7.9B
- IPO Year
- MOD N/A
- JAZZ 2007
- Fundamental
- Price
- MOD $150.44
- JAZZ $136.58
- Analyst Decision
- MOD Strong Buy
- JAZZ Strong Buy
- Analyst Count
- MOD 4
- JAZZ 14
- Target Price
- MOD $154.25
- JAZZ $179.21
- AVG Volume (30 Days)
- MOD 867.3K
- JAZZ 758.5K
- Earning Date
- MOD 10-28-2025
- JAZZ 11-05-2025
- Dividend Yield
- MOD N/A
- JAZZ N/A
- EPS Growth
- MOD 13.98
- JAZZ N/A
- EPS
- MOD 3.49
- JAZZ N/A
- Revenue
- MOD $2,604,800,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- MOD $13.30
- JAZZ $5.70
- Revenue Next Year
- MOD $15.99
- JAZZ $6.16
- P/E Ratio
- MOD $42.93
- JAZZ N/A
- Revenue Growth
- MOD 6.45
- JAZZ 4.52
- 52 Week Low
- MOD $64.79
- JAZZ $95.49
- 52 Week High
- MOD $159.54
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- MOD 56.91
- JAZZ 63.56
- Support Level
- MOD $139.11
- JAZZ $125.79
- Resistance Level
- MOD $150.03
- JAZZ $140.39
- Average True Range (ATR)
- MOD 6.54
- JAZZ 3.18
- MACD
- MOD -0.11
- JAZZ 0.46
- Stochastic Oscillator
- MOD 63.46
- JAZZ 71.59
About MOD Modine Manufacturing Company
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.